08:29 AM EST - Pure Extracts Technologies Corp. : Psyence Group Inc. (CSE: PSYG) and Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) announce the signing of a Joint Venture agreement “Pure Psyence” for the development of nature-derived psilocybin extracts and advanced psilocybin formulations for the long-term treatment of psychological trauma and its mental health consequences. Pure Psyence will leverage Psyence’s supply of high-quality standardized psilocybin mushrooms with Pure Extract’s expertise in extraction technologies to produce high-quality, high-purity medicinal mushroom extracts and formulations on a commercial pharmaceutical scale. Pure Extracts Technologies Corp.
shares C.PULL are trading unchanged at $0.30.
